跳转至内容
Merck
CN
  • Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury.

Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury.

Journal of molecular and cellular cardiology (2015-09-22)
Jennifer A Boylston, Junhui Sun, Yong Chen, Marjan Gucek, Michael N Sack, Elizabeth Murphy
摘要

Succinylation refers to modification of lysine residues with succinyl groups donated by succinyl-CoA. Sirtuin5 (Sirt5) is a mitochondrial NAD(+)-dependent deacylase that catalyzes the removal of succinyl groups from proteins. Sirt5 and protein succinylation are conserved across species, suggesting functional importance of the modification. Sirt5 loss impacts liver metabolism but the role of succinylation in the heart has not been explored. We combined affinity enrichment with proteomics and mass spectrometry to analyze total succinylated lysine content of mitochondria isolated from WT and Sirt5(-/-) mouse hearts. We identified 887 succinylated lysine residues in 184 proteins. 44 peptides (5 proteins) occurred uniquely in WT samples, 289 (46 proteins) in Sirt5(-/-) samples, and 554 (133 proteins) were common to both groups. The 46 unique proteins in Sirt5(-/-) heart participate in metabolic processes such as fatty acid β-oxidation (Eci2) and branched chain amino acid catabolism, and include respiratory chain proteins (Ndufa7, 12, 13, Dhsa). We performed label-free analysis of the peptides common to WT and Sirt5(-/-) hearts. 16 peptides from 9 proteins were significantly increased in Sirt5(-/-) by at least 30%. The adenine nucleotide transporter 1 showed the highest increase in succinylation in Sirt5(-/-) (108.4 fold). The data indicate that succinylation is widespread in the heart and enriched in metabolic pathways. We examined whether the loss of Sirt5 would impact ischemia-reperfusion (I/R) injury and we found an increase in infarct size in Sirt5(-/-) hearts compared to WT littermates (68.5(+)/-1.1% Sirt5(-/-) vs 39.6(+)/(-) 6.8% WT) following 20min of ischemia and 90-min reperfusion. We further demonstrate that I/R injury in Sirt5(-/-) heart is restored to WT levels by pretreatment with dimethyl malonate, a competitive inhibitor of succinate dehydrogenase (SDH), implicating alteration in SDH activity as causative of the injury.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
盐酸胍 盐酸盐, Molecular Biology, ≥99%
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
DL-二硫代苏糖醇 溶液, BioUltra, Molecular Biology, ~1 M in H2O
Supelco
Bradford试剂, for 0.1-1.4 mg/ml protein
Supelco
DL-二硫代苏糖醇 溶液, 1 M in H2O
Sigma-Aldrich
盐酸胍 盐酸盐, organic base and chaeotropic agent, ≥99% (titration)
Sigma-Aldrich
盐酸胍 盐酸盐, ≥98%
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, ≥98.0% (titration)
Sigma-Aldrich
胍 盐酸盐 溶液, BioUltra, ~8 M in H2O
Sigma-Aldrich
胍 盐酸盐 溶液, Colorless liquid, 7.8 - 8.3 M, pH- 4.5 - 5.5
Sigma-Aldrich
丙二酸二甲酯, 98%
Sigma-Aldrich
盐酸胍 盐酸盐, ≥99.0% (AT)
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, ≥98.0%
Sigma-Aldrich
十二烷基硫酸锂, BioReagent, Molecular Biology, suitable for electrophoresis
Sigma-Aldrich
甲酸, ≥95%, FCC, FG
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, BioXtra, ≥98.0% (titration)
Sigma-Aldrich
盐酸胍 盐酸盐, BioUltra, Molecular Biology, ≥99.5% (AT)
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
十二烷基硫酸锂, ≥98.5% (GC)
Sigma-Aldrich
盐酸胍 盐酸盐, anhydrous, free-flowing, Redi-Dri, ≥99%
Sigma-Aldrich
十二烷基硫酸锂, BioXtra, ≥98.5% (GC)
Sigma-Aldrich
二喹啉甲酸 二钠盐 水合物, ≥98% (HPLC)
Sigma-Aldrich
盐酸胍 盐酸盐, Vetec, reagent grade, ≥98%
Sigma-Aldrich
二喹啉甲酸 二钠盐 水合物, Vetec, reagent grade, 98%
Sigma-Aldrich
2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇, Vetec, reagent grade, ≥98%, RNase and DNase free
Sigma-Aldrich
十二烷基硫酸锂, Vetec, reagent grade, ≥98.5%